170 related articles for article (PubMed ID: 18599503)
1. Endothelial EphA receptor stimulation increases lung vascular permeability.
Larson J; Schomberg S; Schroeder W; Carpenter TC
Am J Physiol Lung Cell Mol Physiol; 2008 Sep; 295(3):L431-9. PubMed ID: 18599503
[TBL] [Abstract][Full Text] [Related]
2. EphA2 receptor mediates increased vascular permeability in lung injury due to viral infection and hypoxia.
Cercone MA; Schroeder W; Schomberg S; Carpenter TC
Am J Physiol Lung Cell Mol Physiol; 2009 Nov; 297(5):L856-63. PubMed ID: 19684201
[TBL] [Abstract][Full Text] [Related]
3. Eph-A2 promotes permeability and inflammatory responses to bleomycin-induced lung injury.
Carpenter TC; Schroeder W; Stenmark KR; Schmidt EP
Am J Respir Cell Mol Biol; 2012 Jan; 46(1):40-7. PubMed ID: 21799118
[TBL] [Abstract][Full Text] [Related]
4. Ephrin-A1 facilitates mammary tumor metastasis through an angiogenesis-dependent mechanism mediated by EphA receptor and vascular endothelial growth factor in mice.
Brantley-Sieders DM; Fang WB; Hwang Y; Hicks D; Chen J
Cancer Res; 2006 Nov; 66(21):10315-24. PubMed ID: 17079451
[TBL] [Abstract][Full Text] [Related]
5. Inactivation of EphA2 promotes tight junction formation and impairs angiogenesis in brain endothelial cells.
Zhou N; Zhao WD; Liu DX; Liang Y; Fang WG; Li B; Chen YH
Microvasc Res; 2011 Sep; 82(2):113-21. PubMed ID: 21726568
[TBL] [Abstract][Full Text] [Related]
6. The ephrin-A1 ligand and its receptor, EphA2, are expressed during tumor neovascularization.
Ogawa K; Pasqualini R; Lindberg RA; Kain R; Freeman AL; Pasquale EB
Oncogene; 2000 Dec; 19(52):6043-52. PubMed ID: 11146556
[TBL] [Abstract][Full Text] [Related]
7. EphA receptors and ephrin-A ligands are upregulated by monocytic differentiation/maturation and promote cell adhesion and protrusion formation in HL60 monocytes.
Mukai M; Suruga N; Saeki N; Ogawa K
BMC Cell Biol; 2017 Aug; 18(1):28. PubMed ID: 28851287
[TBL] [Abstract][Full Text] [Related]
8. Ephrin-A1 inhibits NSCLC tumor growth via induction of Cdx-2 a tumor suppressor gene.
Sukka-Ganesh B; Mohammed KA; Kaye F; Goldberg EP; Nasreen N
BMC Cancer; 2012 Jul; 12():309. PubMed ID: 22824143
[TBL] [Abstract][Full Text] [Related]
9. EphA2 receptor tyrosine kinase regulates endothelial cell migration and vascular assembly through phosphoinositide 3-kinase-mediated Rac1 GTPase activation.
Brantley-Sieders DM; Caughron J; Hicks D; Pozzi A; Ruiz JC; Chen J
J Cell Sci; 2004 Apr; 117(Pt 10):2037-49. PubMed ID: 15054110
[TBL] [Abstract][Full Text] [Related]
10. Essential role of Vav family guanine nucleotide exchange factors in EphA receptor-mediated angiogenesis.
Hunter SG; Zhuang G; Brantley-Sieders D; Swat W; Cowan CW; Chen J
Mol Cell Biol; 2006 Jul; 26(13):4830-42. PubMed ID: 16782872
[TBL] [Abstract][Full Text] [Related]
11. VEGFR3 Modulates Vascular Permeability by Controlling VEGF/VEGFR2 Signaling.
Heinolainen K; Karaman S; D'Amico G; Tammela T; Sormunen R; Eklund L; Alitalo K; Zarkada G
Circ Res; 2017 Apr; 120(9):1414-1425. PubMed ID: 28298294
[TBL] [Abstract][Full Text] [Related]
12. Ephrin B3 interacts with multiple EphA receptors and drives migration and invasion in non-small cell lung cancer.
Efazat G; Novak M; Kaminskyy VO; De Petris L; Kanter L; Juntti T; Bergman P; Zhivotovsky B; Lewensohn R; Hååg P; Viktorsson K
Oncotarget; 2016 Sep; 7(37):60332-60347. PubMed ID: 27533087
[TBL] [Abstract][Full Text] [Related]
13. Ephrin-A1 induces c-Cbl phosphorylation and EphA receptor down-regulation in T cells.
Sharfe N; Freywald A; Toro A; Roifman CM
J Immunol; 2003 Jun; 170(12):6024-32. PubMed ID: 12794130
[TBL] [Abstract][Full Text] [Related]
14. Blockade of EphA receptor tyrosine kinase activation inhibits vascular endothelial cell growth factor-induced angiogenesis.
Cheng N; Brantley DM; Liu H; Lin Q; Enriquez M; Gale N; Yancopoulos G; Cerretti DP; Daniel TO; Chen J
Mol Cancer Res; 2002 Nov; 1(1):2-11. PubMed ID: 12496364
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of retinal neovascularization by soluble EphA2 receptor.
Chen J; Hicks D; Brantley-Sieders D; Cheng N; McCollum GW; Qi-Werdich X; Penn J
Exp Eye Res; 2006 Apr; 82(4):664-73. PubMed ID: 16359662
[TBL] [Abstract][Full Text] [Related]
16. Eph and ephrin expression in normal placental development and preeclampsia.
Goldman-Wohl D; Greenfield C; Haimov-Kochman R; Ariel I; Anteby EY; Hochner-Celnikier D; Farhat M; Yagel S
Placenta; 2004 Aug; 25(7):623-30. PubMed ID: 15193868
[TBL] [Abstract][Full Text] [Related]
17. Analysis of ADAM12-Mediated Ephrin-A1 Cleavage and Its Biological Functions.
Ieguchi K; Tomita T; Takao T; Omori T; Mishima T; Shimizu I; Tognolini M; Lodola A; Tsunoda T; Kobayashi S; Wada S; Maru Y
Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33804570
[TBL] [Abstract][Full Text] [Related]
18. Activation of Notch signaling by soluble Dll4 decreases vascular permeability via a cAMP/PKA-dependent pathway.
Boardman R; Pang V; Malhi N; Lynch AP; Leach L; Benest AV; Bates DO; Machado MJC
Am J Physiol Heart Circ Physiol; 2019 May; 316(5):H1065-H1075. PubMed ID: 30681366
[TBL] [Abstract][Full Text] [Related]
19. Placenta growth factor-1 exerts time-dependent stabilization of adherens junctions following VEGF-induced vascular permeability.
Cai J; Wu L; Qi X; Shaw L; Li Calzi S; Caballero S; Jiang WG; Vinores SA; Antonetti D; Ahmed A; Grant MB; Boulton ME
PLoS One; 2011 Mar; 6(3):e18076. PubMed ID: 21464949
[TBL] [Abstract][Full Text] [Related]
20. Higher expression of EphA2 and ephrin-A1 is related to favorable clinicopathological features in pathological stage I non-small cell lung carcinoma.
Ishikawa M; Miyahara R; Sonobe M; Horiuchi M; Mennju T; Nakayama E; Kobayashi M; Kikuchi R; Kitamura J; Imamura N; Huang CL; Date H
Lung Cancer; 2012 Jun; 76(3):431-8. PubMed ID: 22236865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
